Results
ABSCINT
Read more
TOPGUN
Read more
LAVIMA Fertility
Read more
Swave Photonics raises €6M for holographic display technology
Swave Photonics, a spin-off from imec and VUB, has raised an additional €6 million in Series A funding. This follow-on investment will accelerate the development of Swave's innovative holographic display technology for Spatial + AI Computing.
Read more
How VUB spin-offs are reshaping fertility care
From non-invasive embryo selection to hormone-free IVF, VUB innovations are giving fertility care a human-centred upgrade — improving outcomes, access, and safety for people around the world.
Read more
Empowering amputees with a smart bionic foot
What if a prosthetic foot could move as naturally as a biological one? VUB spin-off Axiles Bionics is redefining mobility for lower limb amputees.
Read more
Bringing nature-based resilience to cities
With cities under increasing pressure from floods and heatwaves, BitaGreen transforms urban planning with nature-based solutions that not only protect against climate risks but also improve quality of life.
Read more
Precirix Receives FDA Green Light for Novel Cancer Therapy
VUB spin-off Precirix announced that the U.S. Food and Drug Administration (FDA) has accepted its Investigational New Drug (IND) application for CAM-FAP-Ac-225. This significant achievement paves the way for Precirix to begin a Phase 1 clinical trial for patients battling FAP-positive tumors.
Read more
SALVUS
The ERIS team proudly announces that the SALVUS consortium has received an EU grant. Prof. Rosamunde Van Brakel, from the Law, Science, Technology and Society Research Group of VUB, will coordinate this project for VUB.
Read more
GULLIVER BIOMED
Read more